The Study
Central Nervous System Vasculitis after Starting Methimazole in a Woman with Graves' Disease
This study is like noticing that your friend got a rash after eating a new snack — it might mean the snack caused it, but it could also be something else. One person’s story doesn’t prove anything for everyone else.
Analysis score
Maximum 30 for a case report.
Where the score came from
A woman taking methimazole for her overactive thyroid got a rare brain inflammation called vasculitis. When she stopped the medicine, her brain got better.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 520 / 100
Quality score
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — this is a rare but serious side effect that reversed when the drug was stopped, suggesting a possible link.
- 2Brain scans showed abnormal blood flow; after stopping methimazole, symptoms improved in 5 weeks and scans returned to normal in 6 months.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Thyroid
Year
2008
Authors
P. Tripodi, R. Ruggeri, A. Campenní, M. Cucinotta, A. Mirto, R. Lo Gullo, S. Baldari, F. Trimarchi, D. Cucinotta, G. Russo
Related Content
Claims (2)
Medications that suppress the immune system to treat Graves' disease often cause serious side effects that make them difficult to use in practice.
A woman with Graves' disease developed inflammation of blood vessels in the brain after starting methimazole; this condition improved after stopping the drug, and brain imaging returned to normal six months later.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.